Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24(Suppl 5):v1–v95

Article  PubMed  Google Scholar 

Gartner W, Ilhan A, Neziri D et al (2010) Elevated blood markers 1 year before manifestation of malignant glioma. Neuro Oncol 12(9):1004–1008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sturrock M, Hao W, Schwartzbaum J et al (2015) A mathematical model of pre-diagnostic glioma growth. J Theor Biol 380(7):299–308

Article  PubMed  PubMed Central  Google Scholar 

Kucharczyk MJ, Parpia S, Whitton A et al (2017) Evaluation of pseudoprogression in patients with glioblastoma. Neurooncol Pract 4(2):120–134

PubMed  Google Scholar 

Silantyev AS, Falzone L, Libra M et al (2019) Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics. Cells 8(8):863

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall JW 3rd, Buss E, Grose JH (2016) Factors affecting the development of speech recognition in steady and modulated noise. J Acoust Soc Am 139(5):2964

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Riethdorf S, Wu G et al (2012) Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res 18(20):5701–5710

Article  PubMed  Google Scholar 

Alix-Panabières C, Pantel K (2014) Challenges in circulating tumour cell research. Nat Rev Cancer 14(9):623–631

Article  PubMed  Google Scholar 

Tamai S, Kinoshita M, Sabit H et al (2019) Case of metastatic glioblastoma with primitive neuronal component to the lung. Neuropathology 39(3):218–223

PubMed  Google Scholar 

Sullivan JP, Nahed BV, Madden MW et al (2014) Brain tumor cells in circulation are enriched for mesenchymal gene expression. Cancer Discov 4(11):1299–1309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller C, Holtschmidt J, Auer M et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6(247):247ra101

Article  PubMed  Google Scholar 

Chistiakov DA, Chekhonin VP (2018) Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme. Exp Mol Pathol 105(2):166–174

Article  CAS  PubMed  Google Scholar 

Macarthur KM, Kao GD, Chandrasekaran S et al (2014) Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res 74(8):2152–2159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palande V, Siegal T, Detroja R et al (2022) Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. Mol Oncol 16(10):2098–2114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao F, Cui Y, Jiang H et al (2016) Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget 7(44):71330–71340

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Jiang W, Wang Y et al (2015) MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of glioma. Biomed Rep 3(4):543–548

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piccioni DE, Achrol AS, Kiedrowski LA et al (2019) Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors. CNS Oncol 8(2):Cns3

Google Scholar 

Balaña C, Ramirez JL, Taron M et al (2003) O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9(4):1461–1468

PubMed  Google Scholar 

Dammann R, Li C, Yoon JH et al (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25(3):315–319

Article  CAS  PubMed  Google Scholar 

Horiguchi K, Tomizawa Y, Tosaka M et al (2003) Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene 22(49):7862–7865

Article  CAS  PubMed  Google Scholar 

Chen D, Zhou XZ, Lee TH (2019) Death-associated protein kinase 1 as a promising drug target in cancer and Alzheimer’s disease. Recent Patents Anticancer Drug Discov 14(2):144–157

Article  CAS  Google Scholar 

Khristov V, Lin A, Freedman Z et al (2022) Tumor-derived biomarkers in liquid biopsy of glioblastoma. World Neurosurg. https://doi.org/10.1016/j.wneu.2022.11.012

Article  PubMed  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297

Article  CAS  PubMed  Google Scholar 

Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355

Article  CAS  PubMed  Google Scholar 

Plasterk RH (2006) Micro RNAs in animal development. Cell 124(5):877–881

Article  CAS  PubMed  Google Scholar 

Roth P, Wischhusen J, Happold C et al (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118(3):449–457

Article  CAS  PubMed  Google Scholar 

Sun J, Liao K, Wu X et al (2015) Serum microRNA-128 as a biomarker for diagnosis of glioma. Int J Clin Exp Med 8(1):456–463

CAS  PubMed  PubMed Central  Google Scholar 

Swellam M, Ezz El Arab L, Al-Posttany AS et al (2019) Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform. J Neurooncol 144(3):545–551

Article  CAS  PubMed  Google Scholar 

Swellam M, Bakr NM, El Magdoub HM et al (2021) Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis. J Mol Neurosci 71(4):836–844

Article  CAS  PubMed  Google Scholar 

Lai NS, Wu DG, Fang XG et al (2015) Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br J Cancer 112(7):1241–1246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue X, Lan F, Hu M et al (2016) Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. J Neurosurg 124(1):122–128

Article  CAS  PubMed  Google Scholar 

Zhang H, Wang J, Wang Z et al (2019) Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients. Cancer Biomark 24(1):43–49

Article  CAS  PubMed  Google Scholar 

Jiang L, Mao P, Song L et al (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177(1):29–38

Article  PubMed  PubMed Central  Google Scholar 

Xiao Y, Zhang L, Song Z et al (2016) Potential diagnostic and prognostic value of plasma circulating MicroRNA-182 in human glioma. Med Sci Monit 22:855–862

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang C, Wang C, Chen X et al (2013) Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132(1):116–127

Article  CAS  PubMed  Google Scholar 

Ohno M, Matsuzaki J, Kawauchi J et al (2019) Assessment of the diagnostic utility of serum MicroRNA classification in patients with diffuse glioma. JAMA Netw Open 2(12):e1916953

Article  PubMed  PubMed Central  Google Scholar 

Elstner A, Stockhammer F, Nguyen-Dobinsky TN et al (2011) Identification of diagnostic serum protein profiles of glioblastoma patients. J Neurooncol 102(1):71–80

Article  CAS  PubMed  Google Scholar 

Miyauchi E, Furuta T, Ohtsuki S et al (2018) Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS ONE 13(3):e0193799

Article  PubMed  PubMed Central  Google Scholar 

Furuta T, Sugita Y, Komaki S et al (2020) The Multipotential of Leucine-Rich α-2 glycoprotein 1 as a clinicopathological biomarker of glioblastoma. J Neuropathol Exp Neurol 79(8):873–879